These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20855086)

  • 1. Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation.
    Baker AC; de Mattos A; Watkins S; German JB; Troppmann C; Perez R
    J Surg Res; 2010 Dec; 164(2):182-7. PubMed ID: 20855086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
    Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
    Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney-pancreas transplants: is it so difficult to start a program?
    Alonso A; Fernández C; Villaverde P; García R; Aguirrezabalaga J; Gómez M; Oliver J; Valdés F
    Transplant Proc; 2005 Apr; 37(3):1455-6. PubMed ID: 15866636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplantation in Korean children.
    Kim PK; Kwon MJ
    Transplant Proc; 1996 Jun; 28(3):1172-3. PubMed ID: 8658615
    [No Abstract]   [Full Text] [Related]  

  • 5. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 7. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation.
    Cockfield SM; Moore RB; Todd G; Solez K; Gourishankar S
    Transplantation; 2010 Mar; 89(5):559-66. PubMed ID: 20110855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease.
    Villaverde Verdejo P; Fernández Rivera C; Alonso Hernández A; Garcia Naveiro R; Cao Vilariño M; Tresancos Fernández C; Valdés Cañedo F
    Transplant Proc; 2005 Apr; 37(3):1426-7. PubMed ID: 15866625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
    Vilar E; Varagunam M; Yaqoob MM; Raftery M; Thuraisingham R
    Transplantation; 2010 Jan; 89(1):97-103. PubMed ID: 20061925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.
    Krüger B; Schnitzbauer AA; Böger CA; Hoffmann U; Banas B; Farkas S; Schlitt HJ; Obed A; Krämer BK
    Transplant Proc; 2006 Apr; 38(3):697-700. PubMed ID: 16647448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years.
    Lucarelli G; Bettocchi C; Battaglia M; Impedovo SV; Vavallo A; Grandaliano G; Castellano G; Schena FP; Selvaggi FP; Ditonno P
    Transplant Proc; 2010 May; 42(4):1104-7. PubMed ID: 20534234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
    Parada B; Figueiredo A; Nunes P; Bastos C; Macário F; Roseiro A; Dias V; Rolo F; Mota A
    Transplant Proc; 2005; 37(6):2771-4. PubMed ID: 16182806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of pretransplant inflammatory markers in renal allograft survival and rejection in children.
    Butani L; Johnson J; Troppmann C; McVicar J; Perez RV
    Transplant Proc; 2005 Mar; 37(2):679-81. PubMed ID: 15848499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preemptive living-donor renal transplantation: outcome and clinical advantages.
    Yoo SW; Kwon OJ; Kang CM
    Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
    Sáinz MM; Toro JC; Poblete HB; Perez LF; Nicovani VH; Carrera MG
    Transplant Proc; 2009; 41(6):2655-8. PubMed ID: 19715994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.
    Mitsnefes MM; Khoury PR; McEnery PT
    J Pediatr; 2003 Jul; 143(1):98-103. PubMed ID: 12915832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.